Allergy/Imm Medical News about Prostate Carcinoma

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Novel therapies for children with severe asthma

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Honokiol-mediated Inhibition of PI3K/mTOR Pathway: A Potential Strategy to Overcome Immunoresistance in Glioma, Breast, and Prostate Carcinoma Without Impacting T Cell Function
Journal of Immunotherapy, 06/24/09

Crane C et al. - Data define a unique application for Honokiol and provide the impetus to more fully elucidate the mechanism by which T cells are resistant to the effects of this particular inhibitor. Honokiol is clinically available for human testing and may serve to augment T cell-mediated cancer immunotherapy.

<< Previous
Recombinant Human Granulocyte-macrophage Colony-stimulating...

Next >>
Melan-A/MART1 Analog Peptide Triggers Anti-myeloma T-cells...

Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancer
Cancer Immunology, Immunotherapy, 10/26/09 Relevance Score: 69%

Combined chemotherapy with carboplatin plus irinotecan showed favorable efficacy in a patient with relapsed small cell carcinoma of the prostate complicated with meningeal carcinomatosis
International Journal of Clinical Oncology, 10/30/09 Relevance Score: 67%

Widespread Metastases in Small Cell Carcinoma of the Prostate on FDG PET/CT
Clinical Nuclear Medicine, 10/06/09 Relevance Score: 67%

Testosterone therapy and prostate carcinoma
Current Urology Reports, 11/17/09 Relevance Score: 66%

A pure primary low-grade neuroendocrine carcinoma (carcinoid tumor) of the prostate
International Urology and Nephrology, 11/04/09 Relevance Score: 66%